A subset of familial and sporadic clear cell renal cell carcinomas (ccRCCs) is believed to develop from cystic precursor lesions. Loss of function of the von Hippel-Lindau tumor suppressor gene (VHL) predisposes renal epithelial cells to loss of the primary cilium in response to specific signals. Because the primary cilium suppresses renal cyst formation, loss of the cilium may be an initiating event in the formation of ccRCC. To test this hypothesis, we analyzed the consequences of inducible renal epithelium-specific deletion of Vhl together with ablation of the primary cilium via deletion of the kinesin family member 3A (Kif3a) gene. We developed a microcomputed tomography-based imaging approach to allow quantitative longitudinal monitoring of cystic burden, revealing that combined loss of Vhl and Kif3a shortened the latency of cyst initiation, increased the number of cysts per kidney, and increased the total cystic burden. In contrast with findings in other cystic models, cysts in Kif3a mutant mice did not display accumulation of hypoxia-inducible factor 1-a (HIF1a), and deletion of both Hif1a and Kif3a did not affect cyst development or progression. Vhl/Kif3a double mutation also increased the frequency of cysts that displayed multilayered epithelial growth, which correlated with an increased frequency of misoriented cystic epithelial cell divisions. These results argue against the involvement of HIF1a in promoting renal cyst growth and suggest that the formation of simple and atypical renal cysts that resemble ccRCC precursor lesions is greatly accelerated by the combined loss of Vhl and the primary cilium.
von Hippel-Lindau (VHL) disease is an autosomal dominant genetic disorder caused by inheritance of a mutant allele of the VHL gene. Patients with VHL disease have an increased risk of developing renal cysts and bilateral, multifocal solid or cystic clear cell renal cell carcinomas (ccRCCs), in which the wild-type VHL allele is invariably lost due to somatic mutation or gene silencing. 1 Kidneys of patients with VHL disease develop a spectrum of VHL-deficient lesions that likely represent precursor lesions of solid and cystic ccRCCs, including small foci of microccRCC with a solid appearance, simple cysts lined by a single layer of proliferating epithelial cells, and atypical cysts containing regions of multilayered epithelial growth resembling foci of ccRCC. 2 These findings suggest that ccRCC forms via cyst-dependent and cyst-independent pathways in patients with VHL disease. 3 The VHL gene is also biallelically inactivated in .90% of sporadic ccRCC cases. 4 Although most ccRCCs have a solid morphology, approximately 5% are cystic with small nodular aggregates of clear cell tumor cells within and between the walls of the cysts, 5, 6 suggesting that sporadic ccRCC also arises via cyst-dependent and cyst-independent pathways. pVHL mediates numerous biologic activities, including targeting the a-subunits of the hypoxiainducible transcription factors (HIF1a, HIF2a, and HIF3a) for proteolytic degradation 7 and stabilizing the microtubule network. 8 This latter function of pVHL is important for regulation of the primary cilium, a microtubule-based structure that functions as a sensory organelle for numerous chemical and mechanical stimuli. 9 Genetic mutations that compromise the signaling functions or the structure of the primary cilium cause polycystic kidney diseases. 10 Human ccRCC tumors exhibit extremely low frequencies of ciliated cells 11 and loss of function of VHL in immortalized renal epithelial cells or ccRCC cell lines impairs the formation of primary cilia. [12] [13] [14] However, deletion of Vhl in renal epithelial cells in the mouse kidney or in cultured primary cells does not cause loss of the primary cilium, but sensitizes cells to lose the primary cilium in response to stimulation of the phosphoinositide 3-kinase (PI3K) signaling pathway and inactivation of glycogen synthase kinase 3b. 15, 16 VHL mutant cystic epithelial cells in kidneys of patients with VHL disease frequently lack a primary cilium and display hyperactivation of the PI3K signaling pathway and elevated levels of phosphorylated, inactive glycogen synthase kinase 3b. 15, 16 Loss of the cilium is believed to be a secondary event that occurs in some VHL mutant cells and acts as the trigger for initiation of cyst formation. Combined deletion of Vhl and Pten together in mouse renal epithelial cells, but not of either gene alone, caused renal epithelial cysts with reduced frequencies of ciliated epithelial cells, supporting this hypothesis. 15 However, it was not possible to conclude whether cyst formation results solely from loss of the cilium, from cooperative effects of loss of the cilium plus loss of Vhl, or from cooperative effects of loss of the cilium plus loss of Vhl plus activation of the PI3K pathway. Because Vhl/Pten mice developed diverse benign malignancies in the genital tract that necessitated early euthanasia, 17 it was also not possible to age the mice to determine whether Vhl mutant cystic lesions are able to progress to form ccRCCs. Here we address several of these limitations by generating a mouse model allowing inducible deletion of Vhl together with genetic ablation of primary cilia through deletion of Kif3a, which encodes a protein component of the kinesin-II microtubule motor complex. 18 Loss of pVHL function causes stabilization of HIF1a and HIF2a in epithelial cells of cystic lesions in patients with VHL disease. 2 Recent studies suggest that HIF1a might play a more general role in cystic lesions that arise in genetic conditions other than VHL disease. HIF1a, but not HIF2a, is stabilized in cystic epithelial cells due to microenvironmental hypoxia in a rat model of polycystic kidney disease and in human polycystic kidney disease tissues. 19 Based on two in vitro models of cyst formation, it was proposed that Hif1a activation promotes cyst formation. 20 However, whether HIF1a contributes to the formation or progression of cystic lesions has not been tested in a physiologically relevant cystic model. We tested this idea by deleting Hif1a in the Kif3a-deletion model of kidney cyst formation.
RESULTS
We generated mouse lines allowing inducible renal epitheliumspecific deletion of Kif3a (Ksp1. , respectively. Recombination-specific PCR of genomic DNA isolated from kidneys revealed that all genes were deleted as expected ( Figure 1A ). Although this method of Cre activation leads to some variation between animals in the extent of gene deletion (Supplemental Figure 1K) Figure 1B) were observed at a frequency approximately 10-fold higher than the number of cysts. Similarly, tubules were frequently seen in which some cells displayed elevated staining for Glut-1, a HIF1a-inducible protein and marker of Vhl deletion, whereas other cells were negative for Glut-1. In these tubules, 78% of Glut-1-negative cells but only 4% of Glut-1-positive cells displayed a primary cilium, demonstrating codeletion of Vhl and Kif3a in these cells (Supplemental Figure 1 , H and J). These tubules harboring Vhl/Kif3a mutant cells exhibited no apparent morphologic abnormalities, meaning that cysts were not initiated within 9 months after gene deletion. We conclude that the frequency of gene deletion is not the limiting factor in determining the extent of cyst formation. Staining with markers of different nephron segments revealed that cysts develop from proximal tubules, thick ascending loops of Henle, distal convoluted tubules, collecting ducts, and the urinary pole of the glomerulus (Supplemental Figure 2) , consistent with the expression pattern of the Ksp1.3-Cre ERT2 transgene. 21 To quantitatively monitor cyst formation and progression, we established a microcomputed tomography (mCT)-based imaging technique involving intravascular injection of a contrast agent that is concentrated via the renal tubular system, allowing visualization of the kidney structure. 22 Cysts either do not receive the contrast agent or fail to concentrate it and therefore appear as dark regions in mCT imaging. Mice were imaged at 8, 16, 20, 24, 28, 32 , and 36 weeks after administration of tamoxifen food ( Figure 2 ). Kidneys were isolated and blood plasma was taken after the last time point. mCT imaging revealed no cyst formation in control animals but cyst development in all mutant genotypes. Comparison of mCT images with histologic sections of The majority of cysts in all genotypes were simple cysts lined by a single epithelial layer ( Figure 5, A-C) . In Kif3a D/D and Kif3a D/D ;Hif1a D/D mutant mice, 1.9% (n=204) and 2.1% (n=282) of cysts, respectively, displayed small foci of multilayered or disorganized epithelial growth that projected into the lumen of the cyst ( Figure 5, A and C) . By contrast, in Kif3a D/D ; Vhl D/D mice, the frequency of these atypical cysts was 4-fold higher (8.0%, n=914) ( Figure 5B ). Atypical cysts were also observed in mice that were not subjected to monthly imaging (Supplemental Figure 4D) , indicating that this phenotype is not a secondary effect of the experimental protocol. No tumors were observed in these mice.
Deletion of cyst-suppressing genes early in postnatal development induces a more severe and rapid-onset cystic phenotype than gene deletion in adult kidneys. 21, 23 We injected nursing dams with a dose of tamoxifen that induced a limited number of cysts in the feeding pups and followed these using mCT imaging for 9 months (Supplemental Figure 5 
DISCUSSION
We previously proposed that loss of the microtubule-stabilizing function of pVHL in combination with secondary signaling alterations in the PI3K pathway results in failure of epithelial cells to maintain the primary cilium, causing preneoplastic cyst formation in patients with VHL disease. 3, 15, 16 This study validates this hypothesis but also suggests a modification of the initial model of cyst formation. Combined deletion of Vhl and Kif3a shortens the latency of cyst initiation and increases the total number of cysts and total cystic burden compared with deletion of Kif3a alone, arguing that loss of the primary cilium is not the sole initiating event in cyst formation but that loss of the primary cilium acts cooperatively with loss of pVHL function to induce cyst formation. Because simple cysts are believed to progress to atypical cysts in the cyst-dependent pathway of ccRCC formation, the increased frequency of atypical cysts in Kif3a D/D ;Vhl D/D mice indicates that Vhl loss plus cilium loss promotes the progression toward ccRCC. However, because these lesions persist for at least 6-9 months in mice without progressing to form tumors it is likely that additional mutations that occur frequently in ccRCC such as PBRM1, BAP1, SETD2, or TP53 or PI3K pathway alterations 4, 25 are required to cause tumor formation from these atypical cysts. Consistent with the idea that cilia loss is an early event in ccRCC formation, sporadic human ccRCC tumors exhibit very low frequencies of ciliated cells. 11 Although genomic analyses of ccRCC did not reveal the mutation of genes that encode structural components of primary cilia, 4, 25 activation of the PI3K pathway is a frequent event 4, [25] [26] [27] [28] [29] and is known to cause loss of cilia in VHL null cells. 15, 16 It is possible that other yet-to-be-identified genetic alterations may also cooperate with loss of VHL to cause loss of the cilium. Interestingly, homozygous deletion of Vhl combined with heterozygous deletion of Bap1 during mouse kidney development caused the formation of simple and atypical cysts as well as tumors. 30 The observation that these lesions exhibit high levels of PI3K pathway activation suggests that investigation of the status of primary cilia in these mice is warranted. Because many normal tubules harboring deletion of Vhl and Kif3a do not form cysts within 9 months of gene deletion, it is evident that loss of Vhl together with loss of primary cilia does not automatically lead to cyst formation. Cellular proliferation after damage to nephrons triggers cyst formation in adult kidneys that lack a variety of cyst-predisposing genes. 21, 23 We suggest that the low rate of continuous cell turnover in the adult kidney 31 is the trigger for initiation of cyst formation by Kif3a-or Vhl/Kif3a-deficient cells, with the latter genotype being more sensitized than the former to initiate cyst formation. We observed no increase in proliferation rate of Vhl/Kif3a mutant cells at an early time point after gene deletion, arguing that the increased initiation of cyst formation is not due to alteration in the rate of cellular turnover. A likely contributing factor to increased cyst formation is dysregulation of planar epithelial cell division. During development or repair of a damaged adult kidney tubule, cellular divisions normally orient along the length of the tubule. Misoriented cellular divisions across the plane of the tubule increase the tubular diameter, an initial step in cyst formation. 24 The primary cilium controls oriented cell division via noncanonical WNTand planar cell polarity signaling pathways; loss of cilia, or of several important signaling components of cilia, causes misorientation of cellular division in normal tubules before cysts form. 24 pVHL also controls the plane of cellular division by regulating the stability of the astral microtubule network, thereby ensuring the correct orientation of the mitotic spindle. 32 Ischemic damage to induce cellular proliferation in Vhl null kidney tubules increased the frequency of misoriented epithelial cell divisions, correlating with the formation of microcysts in these animals. 33 Consistent with the idea that Vhl/Kif3a mutation compromises two different mechanisms that ensure oriented cell division, anaphases in cystic epithelia of Kif3a Vhl deletion in mouse proximal tubular epithelial cells caused cyst formation in a small fraction of older mice. 34 Because this phenotype could be rescued by codeletion of Arnt, encoding HIF1b (the dimerization partner of HIF1a and HIF2a that is necessary for transcriptional activation), but not by codeletion of Hif1a, 34 it is possible that the combined activities of HIF1a and HIF2a may promote cyst formation in Kif3a D/D ;Vhl D/D mice. A more general role for HIF1a stabilization in cyst progression has been recently proposed. 19, 20 However, in this study, we find that cystic lesions induced by Kif3a deletion are not characterized by HIF1a stabilization nor does the deletion of Hif1a have any effect on the formation of cysts in this model. HIF1a stabilization may be limited to more severe polycystic kidneys than achieved in this model, or cellular signaling changes induced by mutation of the PKD1/ PKD2 genes in autosomal dominant polycystic kidney disease may contribute to HIF1a activation in cysts through constitutive mammalian target of rapamycin activation, [35] [36] [37] which causes enhanced translation of HIF1a. 38, 39 Finally, these studies have developed and validated a noninvasive method of quantification of cystic burden in mice that should prove useful for future studies investigating the genetic basis of, and therapies for, polycystic kidney diseases and renal cancers.
CONCISE METHODS

Animals
Mice expressing a tamoxifen-inducible kidney-specific Cre recombinase under the Ksp1.3 promoter 40 Office of the Canton of Zurich. Sequences of genotyping primers are given in Supplemental Table 1 .
mCT Imaging
Visipaque 270 (GE Healthcare) was injected intravenously at 8 ml/g body wt as described. 22 mCT images were obtainedwith a Quantum FX microCT (Perkin Elmer) with the following settings: 100 mA, 90 kV, respiratory gating, and fine scanning. mCT data were exported as DICOM images to be analyzed manually with the Myrian software (intrasense) for volumetric measurements and three-dimensional reconstruction and in the Quantum FX data format for overview x-ray pictures.
Immunohistochemistry
Immunohistochemistry and immunofluorescence of formalin-fixed paraffin-embedded kidneys was performed as described 43 with the following antibodies: a-ATPV1B1 (gift from C. Wagner), a-Aqp2 (gift from J. Loffing), BrdU (MAP3510; EMD Millipore), cleaved caspase 3 (9661; Cell Signaling Technology), a-Glut1 (Ab14683; Abcam, Inc.), a-HIF1a (NB100-105; Novus Biologicals ), a-Ki67 (TEC-3; DakoCytomation), a-NaPi (gift from J. Biber), a-NCC (AB3553; EMD Millipore), a-THP (sc-20631; Santa Cruz Biotechnology) and a-acetylated tubulin (T6793; Sigma-Aldrich). Secondary Alexa 488-or Alexa 568-coupled antibodies were from Life Technologies. Horseradish peroxidase -coupled a-mouse secondary antibody was from Thermo Fisher Scientific.
Genomic DNA Quantitative PCR Analyses
Formalin-fixed, paraffin-embedded kidney sections were washed in Xylol for 1 minute twice and air dried. Genomic DNA was isolated from these sections or from powdered whole kidneys with the Arcturus PicoPure DNA Extraction Kit (Life Technologies). Real-time PCR analysis was performed with SYBR FAST Universal 23 qPCR Master Mix and the primers are listed in Supplemental Table 1 .
Blood Plasma Analyses
Animals were anesthetized and blood was collected by puncture of the heart and treated with sodium-heparin. Creatinine and BUN were determined using the UniCel DxC 800 Synchron Clinical System.
